FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Neurontin (gabapentin) by Parke-Davis (Pfizer), resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• NEURONTIN (gabapentin)

Snippet

SUPPL AP for NEURONTIN (GABAPENTIN)